Welcome to our dedicated page for Cerence SEC filings (Ticker: CRNC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Voice AI may make driving effortless, yet deciphering how Cerence monetizes that technology is anything but. Goodwill tests, deferred royalty revenue, and multi-year OEM contracts hide inside sprawling disclosures. Professionals regularly search, “Cerence SEC filings explained simply� or “How to read a Cerence quarterly earnings report 10-Q filing.� They want to know where R&D spend spikes, or why deferred revenue climbs—without wading through 200 pages.
Stock Titan delivers that clarity. We surface Cerence insider trading Form 4 transactions the second they post, plus concise AI annotations that decode each trade. Need Cerence Form 4 insider transactions real-time before the bell, or a Cerence annual report 10-K simplified into segment revenue and backlog? Our AI does the heavy lifting. You’ll also find a Cerence earnings report filing analysis, Cerence 8-K material events explained in plain language, and every Cerence proxy statement executive compensation breakdown, all updated continuously.
Different filings unlock different insights. The 10-K outlines embedded software recognition; the 10-Q captures cloud-service margins; Form 4 details Cerence executive stock transactions Form 4 showing leadership confidence; 8-K alerts flag new automaker partnerships; proxy statements tie pay to voice-assistant milestones. With AI-powered summaries, real-time filing updates, and expert context, understanding Cerence SEC documents with AI becomes straightforward. Track, compare, and act—minus the paperwork grind.
Cerence Inc. insider sale reported. Christian Mentz, EVP and Chief Revenue Officer, sold 4,000 shares of Cerence common stock on 08/14/2025 at a reported price of $12.7358 per share. After the sale, Mr. Mentz beneficially owned 138,747 shares, held directly. The Form 4 was signed by an attorney-in-fact, Jennifer Salinas, on 08/18/2025 and states the transaction represents shares sold by the reporting person.
Cerence Inc. (CRNC) filed a Form 144 notice reporting a proposed sale of 4,000 shares of common stock, with an aggregate market value of $50,943.20. The shares are part of an issuance recorded as restricted stock acquired from the issuer on 10/01/2024 and were paid in full on that date. The filing names Morgan Stanley Smith Barney LLC as the broker and lists an approximate sale date of 08/14/2025 on the NASDAQ. Total shares outstanding are reported as 43,319,651. The filer affirms they do not possess undisclosed material adverse information about the issuer.
FAQ
What is the current stock price of Cerence (CRNC)?
What is the market cap of Cerence (CRNC)?
